Technetium tc-99m trofolastat chloride clinical trials
Also written 99mTc-MIP-1404.
How each study uses technetium tc-99m trofolastat chloride is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2012 (4)
| Year | Studies |
|---|---|
| 2012 | 4 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Related medicines
As reviewed, each with the page that says it.
- One of Radiopharmaceuticals source
Studies
Open first, then newest update. How each study uses technetium tc-99m trofolastat chloride is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate CancerCompletedPhase 3Molecular Insight Pharmaceuticals, Inc.NCT02615067Written as 99mTc-MIP-1404 InjectionHow we know
- A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to HistopathologyCompletedPhase 2Molecular Insight Pharmaceuticals, Inc.NCT01667536Written as Drug: 99mTc-MIP-1404How we know
- 99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404CompletedPhase 1Molecular Insight Pharmaceuticals, Inc.NCT01654874Written as 99mTc-MIP-1404How we know
- Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node DissectionCompletedPhase 1Molecular Insight Pharmaceuticals, Inc.NCT01572701Written as 99mTc-MIP-1404How we know
- A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate CancerCompletedPhase 1Molecular Insight Pharmaceuticals, Inc.NCT01615406Written as 99mTc MIP 1404How we know
Codes
What other systems call technetium tc-99m trofolastat chloride · ClinicalTrials.gg INT000183
- UNII (FDA) 45WAL7ZXQTTECHNETIUM TC-99M TROFOLASTAT CHLORIDEOne source FDA
- NCI Thesaurus C152532Technetium Tc-99M Trofolastat ChlorideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 45WAL7ZXQT | TECHNETIUM TC-99M TROFOLASTAT CHLORIDE | One source FDA |
| NCI Thesaurus | C152532 | Technetium Tc-99M Trofolastat Chloride | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.